Natural Products Derived from Marine Sponges with Antitumor Potential against Lung Cancer: A Systematic Review
Marine Drugs · 2024
DOI: 10.3390/md22030101 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Marine Drugs, 2024. Verfasst von Alba Ortigosa-Palomo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biopathology and Regenerative Medicine (IBIMER), Biomedical Research Center (CIBM), 18100 Granada, Spain. Hauptthemen laut MEDLINE: Porifera, Biological Products, Lung Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Granada, Granada University.
Abstract (Originalsprache)
Non-small-cell lung cancer (NSCLC), the most commonly diagnosed cancer and the leading cause of cancer-related death worldwide, has been extensively investigated in the last decade in terms of developing new therapeutic options that increase patient survival. In this context, marine animals are a source of new, interesting bioactive molecules that have been applied to the treatment of different types of cancer. Many efforts have been made to search for new therapeutic strategies to improve the prognosis of lung cancer patients, including new bioactive compounds and cytotoxic drugs from marine sponges. Their antitumoral effect can be explained by several cellular and molecular mechanisms, such as modulation of the cell cycle or induction of apoptosis. Thus, this systematic review aims to summarize the bioactive compounds derived from marine sponges and the mechanisms by which they show antitumor effects against lung cancer, exploring their limitations and the challenges associated with their discovery. The search process was performed in three databases (PubMed, SCOPUS, and Web of Science), yielding a total of 105 articles identified in the last 10 years, and after a screening process, 33 articles were included in this systematic review. The results showed that these natural sponge-derived compounds are a valuable source of inspiration for the development of new drugs. However, more research in this field is needed for the translation of these novel compounds to the clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biopathology and Regenerative Medicine (IBIMER), Biomedical Research Center (CIBM), 18100 Granada, Spain.
- Instituto Biosanitario de Granada, (ibs.GRANADA), SAS-Universidad de Granada, 18012 Granada, Spain.
- Department of Anatomy and Embryology, University of Granada, 18071 Granada, Spain.
- Department of Organic Chemistry, Faculty of Sciences, University of Malaga, 29071 Malaga, Spain.
ORCID-Profile: Alba Ortigosa-Palomo, Francisco Quiñonero, Francisco Sarabia, Jose Prados, Consolación Melguizo
Förderung
- University of Granada
- Granada University
Zitieren
APA
Ortigosa-Palomo, A., Quiñonero, F., Ortiz, R., Sarabia, F., Prados, J., & Melguizo, C. (2024). Natural Products Derived from Marine Sponges with Antitumor Potential against Lung Cancer: A Systematic Review. Marine Drugs. https://doi.org/10.3390/md22030101
Vancouver
Ortigosa-Palomo A, Quiñonero F, Ortiz R, Sarabia F, Prados J, Melguizo C. Natural Products Derived from Marine Sponges with Antitumor Potential against Lung Cancer: A Systematic Review. Marine Drugs. 2024. doi:10.3390/md22030101
BibTeX
@article{OrtigosaPalomo2024,
author = {Ortigosa-Palomo, Alba and Quiñonero, Francisco and Ortiz, Raul and Sarabia, Francisco and Prados, Jose and Melguizo, Consolación},
title = {Natural Products Derived from Marine Sponges with Antitumor Potential against Lung Cancer: A Systematic Review},
journal = {Marine Drugs},
year = {2024},
doi = {10.3390/md22030101}
}
EUVIMED